+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study



Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study



International Journal of Gynecological Cancer 16(3): 955-962



Hybrid capture II (HC II) test for oncogenic human papillomaviruses (HPV) was carried out in a cohort of 4284 women at their first clinical visit. Overall prevalence of HPV was 17.1%, decreasing with age from 33.9% among women below 20 years to only 11.0% among those older than 41 years. HPV prevalence was significantly higher among current smokers (odds ratio [OR] = 1.31; 95% CI 1.1-1.6), in women with two or more lifetime sexual partners (OR = 1.9; 95% CI 1.6-2.4), and those women with two or more sexual partners during the past 12 months prior to examination (OR = 1.6; 95% CI 1.2-2.2). HPV detection increased in parallel with increasing cytologic abnormality, being highest in women with high-grade squamous intraepithelial lesion (P= 0.001). Specificity of the HPV test in detecting histologically confirmed cervical disease was 85% (95% CI 83.9-86.1). Sensitivity of the HPV test in detecting histologic abnormalities increased in parallel with disease severity, ranging from 51.5% for cervical intraepithelial neoplasia (CIN) 1 to 96.5% for CIN 3 and 100.0% for cancer, with respective decline of positive predictive value. These data suggest that HPV testing with HC II assay might be a viable screening tool among this population with relatively high prevalence of cervical disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049253361

Download citation: RISBibTeXText

PMID: 16803469

DOI: 10.1111/j.1525-1438.2006.00582.x


Related references

Value of conventional pap smear, liquid-based cytology, visual inspection and human papillomavirus testing as optional screening tools among latin american women <35 and > or =35 years of age: experience from the Latin American Screening Study. Acta Cytologica 52(6): 641-653, 2009

Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study. Acta Cytologica 49(5): 500-506, 2005

HPV Testing in Resource-Limited Settings: How Can We Reach the Next Level of Cervical Cancer Screening in Latin America and the Caribbean?. Oncologist 20(10): 1101-1104, 2015

Evaluation of Visual Inspection with Acetic Acid (VIA), Lugol's iodine (VILI), Cervical Cytology and HPV Testing as Cervical Screening Tools in Latin America. This Report Refers to Partial Results from the LAMS (Latin AMerican Screening) Study. Journal of Lower Genital Tract Disease 10(2): 129-130, 2006

Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study. Journal of Medical Screening 12(3): 142-149, 2005

Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Research 25(5): 3469-3480, 2005

Pap smear cytology, visual inspection , cervicography, colposcopy and HPV testing by hybrid capture II as optional screening tools in Latin America. Virchows Archiv 443(3): 268, 2003

Conventional Pap Smear and Liquid-Based Cytology as Screening Tools in Low-Resource Settings in Latin America. Acta Cytologica 49(5): 500-506, 2005

Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study. Sexually Transmitted Diseases 36(4): 241-248, 2009

Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean. Vaccine 26(Suppl. 11): L88-L95, 2008

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. Journal of the National Cancer Institute 92(10): 818-825, 2000

Interlaboratory quality control of PAP smear cytology as a part of the multi-centre trial comparing six optional screening tools in Latin America. Virchows Archiv 443(3): 256, 2003

Optional screening strategies for cervical cancer using standalone tests and their combinations among low- and medium-income populations in Latin America and Eastern Europe. Journal of Medical Screening 17(4): 195-203, 2010

Chagas disease screening among Latin American immigrants in non-endemic settings. Travel Medicine and Infectious Disease 6(3): 162-163, 2008

Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries. Latin American Diabetes Association. Revista Panamericana de Salud Publica 28(6): 463-471, 2011